Agios Pharmaceuticals, Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| FARALLON CAPITAL MANAGEMENT LLC | 05/15/2025 | 5.70 M | $167.02 M | 0.46% | 9.92% |
| VANGUARD GROUP INC | 05/09/2025 | 5.60 M | $164.21 M | -0.47% | 9.75% |
| BLACKROCK, INC. | 05/02/2025 | 5.11 M | $149.69 M | 1.84% | 8.89% |
| BELLEVUE GROUP AG | 05/14/2025 | 3.52 M | $102.99 M | 0.00% | 6.12% |
| STATE STREET CORP | 05/15/2025 | 2.45 M | $71.77 M | 13.81% | 4.26% |
| PRICE T ROWE ASSOCIATES INC /MD/ | 05/14/2025 | 2.30 M | $67.43 M | -5.04% | 4.01% |
| 05/14/2025 | 2.23 M | $65.44 M | 10.95% | 3.88% | |
| COMMODORE CAPITAL LP | 05/15/2025 | 2.19 M | $64.02 M | 100.00% | 3.80% |
| ARMISTICE CAPITAL, LLC | 05/15/2025 | 2.05 M | $60.01 M | -9.55% | 3.56% |
| MACQUARIE GROUP LTD | 05/15/2025 | 1.85 M | $54.22 M | 9.83% | 3.22% |
| GEODE CAPITAL MANAGEMENT, LLC | 05/13/2025 | 1.39 M | $40.87 M | 3.33% | 2.43% |
| DIMENSIONAL FUND ADVISORS LP | 05/13/2025 | 1.26 M | $36.98 M | -5.04% | 2.20% |
| BANK OF AMERICA CORP /DE/ | 05/15/2025 | 1.14 M | $33.27 M | 180.46% | 1.98% |
| FRAZIER LIFE SCIENCES MANAGEMENT, L.P. | 05/15/2025 | 1.07 M | $31.35 M | 0.01% | 1.86% |
| JPMORGAN CHASE & CO | 05/12/2025 | 1.05 M | $30.75 M | 3.35% | 1.83% |
| BNP PARIBAS ASSET MANAGEMENT HOLDING S.A. | 05/14/2025 | 1.03 M | $30.05 M | 8.87% | 1.79% |
| POLAR CAPITAL HOLDINGS PLC | 05/15/2025 | 1.00 M | $29.36 M | 59.81% | 1.74% |
| FISHER ASSET MANAGEMENT, LLC | 05/14/2025 | 959.34 K | $28.11 M | -0.14% | 1.67% |
| DEUTSCHE BANK AG\ | 05/09/2025 | 928.97 K | $27.22 M | -0.67% | 1.62% |
| CITADEL ADVISORS LLC | 05/15/2025 | 863.50 K | $25.30 M | -39.77% | 1.50% |
| ARROWMARK COLORADO HOLDINGS LLC | 05/15/2025 | 827.62 K | $24.25 M | -9.79% | 1.44% |
| GW&K INVESTMENT MANAGEMENT, LLC | 05/05/2025 | 817.53 K | $23.95 M | 19.62% | 1.42% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 05/15/2025 | 743.00 K | $21.77 M | 145.21% | 1.29% |
| CALIGAN PARTNERS LP | 05/15/2025 | 701.28 K | $20.55 M | 11.98% | 1.22% |
| GOLDMAN SACHS GROUP INC | 06/27/2025 | 658.65 K | $19.30 M | 16.13% | 1.15% |
| SCS CAPITAL MANAGEMENT LLC | 05/19/2025 | 611.10 K | $17.91 M | 100.00% | 1.06% |
| NORTHERN TRUST CORP | 05/13/2025 | 576.26 K | $16.88 M | -3.23% | 1.00% |
| D. E. SHAW & CO., INC. | 05/15/2025 | 554.82 K | $16.26 M | 7.42% | 0.97% |
| MARSHALL WACE, LLP | 05/15/2025 | 520.87 K | $15.26 M | -17.53% | 0.91% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 05/09/2025 | 464.96 K | $13.62 M | -1.61% | 0.81% |
| ARTISAN PARTNERS LIMITED PARTNERSHIP | 05/14/2025 | 410.67 K | $12.03 M | -17.72% | 0.71% |
| CONNOR, CLARK & LUNN INVESTMENT MANAGEMENT LTD. | 05/12/2025 | 386.52 K | $11.33 M | 207.55% | 0.67% |
| VOLORIDGE INVESTMENT MANAGEMENT, LLC | 05/15/2025 | 331.64 K | $9.72 M | 65.42% | 0.58% |
| EAGLE HEALTH INVESTMENTS LP | 05/12/2025 | 330.83 K | $9.69 M | 0.00% | 0.58% |
| ORBIMED ADVISORS LLC | 05/15/2025 | 325.50 K | $9.54 M | 1,119.10% | 0.57% |
| PICTET ASSET MANAGEMENT HOLDING SA | 05/05/2025 | 310.78 K | $9.40 M | -12.32% | 0.54% |
| MORGAN STANLEY | 05/15/2025 | 294.62 K | $8.63 M | -22.08% | 0.51% |
| PALO ALTO INVESTORS LP | 05/15/2025 | 276.58 K | $8.10 M | 100.00% | 0.48% |
| BANK OF NEW YORK MELLON CORP | 04/29/2025 | 263.45 K | $7.72 M | -0.78% | 0.46% |
| BOOTHBAY FUND MANAGEMENT, LLC | 05/15/2025 | 261.22 K | $7.65 M | 3.75% | 0.45% |
| CASDIN CAPITAL, LLC | 05/15/2025 | 250.00 K | $7.33 M | 0.00% | 0.44% |
| CUTTER CAPITAL MANAGEMENT, LP | 05/15/2025 | 235.35 K | $6.90 M | -21.97% | 0.41% |
| AXA S.A. | 05/15/2025 | 225.12 K | $6.60 M | 28.36% | 0.39% |
| NORDEA INVESTMENT MANAGEMENT AB | 05/14/2025 | 224.17 K | $6.51 M | 1.63% | 0.39% |
| PRUDENTIAL FINANCIAL INC | 05/13/2025 | 204.24 K | $5.98 M | 94.66% | 0.36% |
| TD ASSET MANAGEMENT INC | 05/07/2025 | 178.07 K | $5.22 M | 7.48% | 0.31% |
| CITIGROUP INC | 05/12/2025 | 176.13 K | $5.16 M | -8.81% | 0.31% |
| WALLEYE CAPITAL LLC | 05/14/2025 | 150.51 K | $4.41 M | -24.57% | 0.26% |
| UBS ASSET MANAGEMENT AMERICAS INC | 05/19/2025 | 147.28 K | $4.32 M | 19.90% | 0.26% |
| PATIENT SQUARE CAPITAL LP | 05/14/2025 | 139.73 K | $4.09 M | 14.79% | 0.24% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Agios Pharmaceuticals, Inc. institutional Ownership - FAQ's
During the previous two years, 314 institutional investors and hedge funds held shares of Agios Pharmaceuticals, Inc.. The most heavily invested institutionals were:
FARALLON CAPITAL MANAGEMENT LLC: 5.7 M
VANGUARD GROUP INC: 5.6 M
BlackRock, Inc.: 5.11 M
Bellevue Group AG: 3.52 M
STATE STREET CORP: 2.45 M
PRICE T ROWE ASSOCIATES INC /MD/: 2.3 M
103.77% of Agios Pharmaceuticals, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 75.83 M shares in the last 24 months. This purchase volume represents approximately $2.74 B in transactions.